In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.

Ex Input:
SECTION 1. SHORT TITLE.

    This Act may be cited as the ``National Center for Social Work 
Research Act''.

SEC. 2. FINDINGS.

    The Congress finds as follows:
            (1) Social workers focus on the improvement of individual 
        and family functioning and the creation of effective health and 
        mental health prevention and treatment interventions in order 
        for individuals to become more productive members of society.
            (2) Social workers provide front line prevention and 
        treatment services in the areas of school violence, aging, teen 
        pregnancy, child abuse, domestic violence, juvenile crime, and 
        substance abuse, particularly in rural and underserved 
        communities.
            (3) Social workers are in a unique position to provide 
        valuable research information on these complex social concerns, 
        taking into account a wide range of social, medical, economic 
        and community influences from an interdisciplinary, family-
        centered and community-based approach.

SEC. 3. ESTABLISHMENT OF NATIONAL CENTER FOR SOCIAL WORK RESEARCH.

    Title IV of the Public Health Service Act (42 U.S.C. 281 et seq.), 
as amended by title I of Public Law 106-525, is amended--
            (1) in section 401(b)(2) (42 U.S.C. 281(b)(2)), by adding 
        at the end the following:
            ``(H) The National Center for Social Work Research.''; and
            (2) in part E (42 U.S.C. 287 et seq.), by adding at the end 
        the following:

         ``Subpart 7--National Center for Social Work Research

``SEC. 485J. PURPOSE OF CENTER.

    ``The general purpose of the National Center for Social Work 
Research (referred to in this subpart as the `Center') is the conduct 
and support of, and dissemination of targeted research on social work 
methods and outcomes related to problems of significant social concern. 
The Center shall promote research and training designed to inform 
social work practice, thus increasing the knowledge base which promotes 
a healthier America. In addition, the Center shall provide policymakers 
with empirically-based research information to better understand 
complex social issues and make informed funding decisions about service 
effectiveness and cost efficiency.

``SEC. 485K. SPECIFIC AUTHORITIES.

    ``(a) In General.--To carry out the purpose described in section 
485J, the Director of the Center may provide research training and 
instruction and establish, in the Center and in other nonprofit 
institutions, research traineeships and fellowships in the study and 
investigation of the prevention of disease, health promotion, the 
association of socioeconomic status, gender, ethnicity, age, and 
geographical location and health, the social work care of persons with 
and families of individuals with acute and chronic illnesses, child 
abuse, neglect, and youth violence, and child and family care to 
address problems of significant social concern especially in 
underserved populations and underserved geographical areas.
    ``(b) Stipends and Allowances.--The Director of the Center may 
provide individuals receiving training and instruction or traineeships 
or fellowships under subsection (a) with such stipends and allowances 
(including amounts for travel and subsistence and dependency 
allowances) as the Director determines necessary.
    ``(c) Grants.--The Director of the Center may make grants to 
nonprofit institutions to provide training and instruction and 
traineeships and fellowships under subsection (a).

``SEC. 485L. ADVISORY COUNCIL.

    ``(a) Duties.--
            ``(1) In general.--The Secretary shall establish an 
        advisory council for the Center that shall advise, assist, 
        consult with, and make recommendations to the Secretary and the 
        Director of the Center on matters related to the activities 
carried out by and through the Center and the policies with respect to 
such activities.
            ``(2) Gifts.--The advisory council for the Center may 
        recommend to the Secretary the acceptance, in accordance with 
        section 231, of conditional gifts for study, investigations, 
        and research and for the acquisition of grounds or 
        construction, equipment, or maintenance of facilities for the 
        Center.
            ``(3) Other duties and functions.--The advisory council for 
        the Center--
                    ``(A)(i) may make recommendations to the Director 
                of the Center with respect to research to be conducted 
                by the Center;
                    ``(ii) may review applications for grants and 
                cooperative agreements for research or training and 
                recommend for approval applications for projects that 
                demonstrate the probability of making valuable 
                contributions to human knowledge; and
                    ``(iii) may review any grant, contract, or 
                cooperative agreement proposed to be made or entered 
                into by the Center;
                    ``(B) may collect, by correspondence or by personal 
                investigation, information relating to studies that are 
                being carried out in the United States or any other 
                country and, with the approval of the Director of the 
                Center, make such information available through 
                appropriate publications; and
                    ``(C) may appoint subcommittees and convene 
                workshops and conferences.
    ``(b) Membership.--
            ``(1) In general.--The advisory council shall be composed 
        of the ex officio members described in paragraph (2) and not 
        more than 18 individuals to be appointed by the Secretary under 
        paragraph (3).
            ``(2) Ex officio members.--The ex officio members of the 
        advisory council shall include--
                    ``(A) the Secretary of Health and Human Services, 
                the Director of NIH, the Director of the Center, the 
                Chief Social Work Officer of the Veterans' 
                Administration, the Assistant Secretary of Defense for 
                Health Affairs, the Associate Director of Prevention 
                Research at the National Institute of Mental Health, 
                the Director of the Division of Epidemiology and 
                Services Research, the Assistant Secretary of Health 
                and Human Services for the Administration for Children 
                and Families, the Assistant Secretary of Education for 
                the Office of Educational Research and Improvement, the 
                Assistant Secretary of Housing and Urban Development 
                for Community Planning and Development, and the 
                Assistant Attorney General for Office of Justice 
                Programs (or the designees of such officers); and
                    ``(B) such additional officers or employees of the 
                United States as the Secretary determines necessary for 
                the advisory council to effectively carry out its 
                functions.
            ``(3) Appointed members.--The Secretary shall appoint not 
        to exceed 18 individuals to the advisory council, of which--
                    ``(A) not more than two-thirds of such individual 
                shall be appointed from among the leading 
                representatives of the health and scientific 
                disciplines (including public health and the behavioral 
                or social sciences) relevant to the activities of the 
                Center, and at least 7 such individuals shall be 
                professional social workers who are recognized experts 
                in the area of clinical practice, education, policy, or 
                research; and
                    ``(B) not more than one-third of such individuals 
                shall be appointed from the general public and shall 
                include leaders in fields of public policy, law, health 
                policy, economics, and management.
        The Secretary shall make appointments to the advisory council 
        in such a manner as to ensure that the terms of the members do 
        not all expire in the same year.
            ``(4) Compensation.--Members of the advisory council who 
        are officers or employees of the United States shall not 
        receive any compensation for service on the advisory council. 
        The remaining members shall receive, for each day (including 
        travel time) they are engaged in the performance of the 
        functions of the advisory council, compensation at rates not to 
        exceed the daily equivalent of the annual rate in effect for an 
        individual at grade GS-18 of the General Schedule.
    ``(c) Terms.--
            ``(1) In general.--The term of office of an individual 
        appointed to the advisory council under subsection (b)(3) shall 
        be 4 years, except that any individual appointed to fill a 
        vacancy on the advisory council shall serve for the remainder 
        of the unexpired term. A member may serve after the 
expiration of the member's term until a successor has been appointed.
            ``(2) Reappointments.--A member of the advisory council who 
        has been appointed under subsection (b)(3) for a term of 4 
        years may not be reappointed to the advisory council prior to 
        the expiration of the 2-year period beginning on the date on 
        which the prior term expired.
            ``(3) Vacancy.--If a vacancy occurs on the advisory council 
        among the members under subsection (b)(3), the Secretary shall 
        make an appointment to fill that vacancy not later than 90 days 
        after the date on which the vacancy occurs.
    ``(d) Chairperson.--The chairperson of the advisory council shall 
be selected by the Secretary from among the members appointed under 
subsection (b)(3), except that the Secretary may select the Director of 
the Center to be the chairperson of the advisory council. The term of 
office of the chairperson shall be 2 years.
    ``(e) Meetings.--The advisory council shall meet at the call of the 
chairperson or upon the request of the Director of the Center, but not 
less than 3 times each fiscal year. The location of the meetings of the 
advisory council shall be subject to the approval of the Director of 
the Center.
    ``(f) Administrative Provisions.--The Director of the Center shall 
designate a member of the staff of the Center to serve as the executive 
secretary of the advisory council. The Director of the Center shall 
make available to the advisory council such staff, information, and 
other assistance as the council may require to carry out its functions. 
The Director of the Center shall provide orientation and training for 
new members of the advisory council to provide such members with such 
information and training as may be appropriate for their effective 
participation in the functions of the advisory council.
    ``(g) Comments and Recommendations.--The advisory council may 
prepare, for inclusion in the biennial report under section 485M--
            ``(1) comments with respect to the activities of the 
        advisory council in the fiscal years for which the report is 
        prepared;
            ``(2) comments on the progress of the Center in meeting its 
        objectives; and
            ``(3) recommendations with respect to the future direction 
        and program and policy emphasis of the center.
The advisory council may prepare such additional reports as it may 
determine appropriate.

``SEC. 485M. BIENNIAL REPORT.

    ``The Director of the Center, after consultation with the advisory 
council for the Center, shall prepare for inclusion in the biennial 
report under section 403, a biennial report that shall consist of a 
description of the activities of the Center and program policies of the 
Director of the Center in the fiscal years for which the report is 
prepared. The Director of the Center may prepare such additional 
reports as the Director determines appropriate. The Director of the 
Center shall provide the advisory council of the Center an opportunity 
for the submission of the written comments described in section 
485L(g).

``SEC. 485N. QUARTERLY REPORT.

    ``The Director of the Center shall prepare a quarterly report to 
Congress with a summary of findings and policy implications from 
research conducted or supported through the Center.

``SEC. 485O. AUTHORIZATION OF APPROPRIATIONS.

    ``For the purpose of carrying out this subpart, there is authorized 
to be appropriated $30,000,000 for each of the fiscal years 2002 
through 2006.''.

Ex Output:
National Center for Social Work Research Act - Amends the Public Health Service Act to establish the National Center for Social Work Research (and a related advisory council) to conduct, support, and disseminate targeted research on social work methods and outcomes related to problems of significant social concern.Sets forth reporting requirements.


Ex Input:
SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Right to Try Act''.

SEC. 2. USE OF UNAPPROVED MEDICAL PRODUCTS BY PATIENTS DIAGNOSED WITH A 
              TERMINAL ILLNESS.

    (a) In General.--Notwithstanding the Federal Food, Drug, and 
Cosmetic Act (21 U.S.C. 301 et seq.), the Controlled Substances Act (21 
U.S.C. 801 et seq.), and any other provision of Federal law, the 
Federal Government shall not take any action to prohibit or restrict--
            (1) the production, manufacture, distribution, prescribing, 
        or dispensing of an experimental drug, biological product, or 
        device that--
                    (A) is intended to treat a patient who has been 
                diagnosed with a terminal illness; and
                    (B) is authorized by, and in accordance with, State 
                law; and
            (2) the possession or use of an experimental drug, 
        biological product, or device--
                    (A) that is described in subparagraphs (A) and (B) 
                of paragraph (1); and
                    (B) for which the patient has received a 
                certification from the patient's treating physician in 
                accordance with subsection (b).
    (b) Physician Certification.--A certification by the patient's 
treating physician referred to in subsection (a)(2)(B) must include 
each of the following:
            (1) A certification that the physician--
                    (A) is in good standing with the physician's 
                certifying organization or board; and
                    (B) has personally examined the patient.
            (2) A certification that there is no reason to conclude the 
        experimental drug, biological product, or device poses an 
        unreasonable and significant risk of danger to the patient.
            (3) A certification that the patient has been diagnosed 
        with a terminal disease or condition and does not have any 
        treatment options that--
                    (A) are comparable to treatment using the 
                experimental drug, biological product, or device or 
                otherwise satisfactory; and
                    (B) are approved, licensed, or cleared for 
                commercial distribution under section 505, 510(k), or 
                515 of the Federal Food, Drug, and Cosmetic Act (21 
                U.S.C. 355, 360(k), 360(e)) or section 351 of the 
                Public Health Service Act (42 U.S.C. 262) and are 
                available to diagnose, monitor, or treat the patient's 
                disease or condition.
            (4) A certification that the probable risk to the patient 
        from the experimental drug, biological product, or device is 
        not greater than the probable risk from the patient's disease 
        or condition.
            (5) A certification that the physician has provided the 
        patient with a written statement and oral explanation of the 
        medical treatment to be provided using the experimental drug, 
        biological product, or device.
            (6) An acknowledgement signed by the patient (or the 
        patient's legal representative) that the physician has provided 
        the written statement and oral explanation required by 
        paragraph (5), and has disclosed the following:
                    (A) That the medical treatment using the 
                experimental drug, biological product, or device is 
                experimental or nonconventional.
                    (B) That the experimental drug, biological product, 
                or device has not been approved, licensed, or cleared 
                for commercial distribution under section 505, 510(k), 
                or 515 of the Federal Food, Drug, and Cosmetic Act (21 
                U.S.C. 355, 360(k), 360(e)) or section 351 of the 
                Public Health Service Act (42 U.S.C. 262) for any 
                indication.
                    (C) The material risks generally recognized by a 
                reasonably prudent physician of the medical treatment's 
                side effects.
                    (D) An explanation of the medical treatment, 
                including the expected frequency and duration of the 
                treatment.
    (c) No Liability or Use of Outcomes.--
            (1) No liability.--Notwithstanding any other provision of 
        law, no liability shall lie against a producer, manufacturer, 
        distributor, prescriber, dispenser, possessor, or user of an 
        experimental drug, biological product, or device for the 
        production, manufacture, distribution, prescribing, dispensing, 
        possession, or use of an experimental drug, biological product, 
        or device that is in compliance, with subsection (a).
            (2) No use of outcomes.--Notwithstanding any other 
        provision of law, the outcome of any production, manufacture, 
        distribution, prescribing, dispensing, possession, or use of an 
        experimental drug, biological product, or device that was done 
        in compliance with subsection (a) shall not be used by a 
        Federal agency reviewing the experimental drug, biological 
        product, or device to delay or otherwise adversely impact 
        review or approval of such experimental drug, biological 
        product, or device.
    (d) Rules of Construction.--Nothing in this Act shall be construed 
to--
            (1) require a manufacturer or other person to make 
        available any experimental drug, biological product, or device; 
        or
            (2) prohibit a manufacturer or other person from receiving 
        compensation or recovering costs for the production, 
        manufacture, distribution, or sale of an experiment drug, 
        biological product, or device.
    (e) Definitions.--In this section:
            (1) Biological product.--The term ``biological product'' 
        has the meaning given to such term in section 351 of the Public 
        Health Service Act (42 U.S.C. 262).
            (2) Device; drug.--The terms ``device'' and ``drug'' have 
        the meanings given to such terms in section 201 of the Federal 
        Food, Drug, and Cosmetic Act (21 U.S.C. 321).
            (3) Experimental drug, biological product, or device.--The 
        term ``experimental drug, biological product, or device'' means 
        a drug, biological product, or device that--
                    (A) has successfully completed a phase 1 clinical 
                investigation;
                    (B) remains under investigation in a clinical trial 
                approved by the Food and Drug Administration; and
                    (C) is not approved, licensed, or cleared for 
                commercial distribution under section 505, 510(k), or 
                515 of the Federal Food, Drug, and Cosmetic Act (21 
                U.S.C. 355, 360(k), 360(e)) or section 351 of the 
                Public Health Service Act (42 U.S.C. 262).
            (4) Phase 1 clinical investigation.--The term ``phase 1 
        clinical investigation'' means a phase 1 clinical 
        investigation, as described in section 312.21 of title 21, Code 
        of Federal Regulations (or any successor regulations).
            (5) Terminal illness.--The term ``terminal illness'' has 
        the meaning given to such term in the State law specified in 
        subsection (a)(1)(B).

Ex Output:
Right to Try Act This bill requires the federal government to allow unrestricted manufacturing, distribution, prescribing, and dispensing of experimental drugs, biological products, and medical devices that are authorized by state law and intended to treat terminally ill patients. Patients receiving these treatments must be certified by a physician as having exhausted all other treatment options and as being at greater risk from their medical condition than the treatment. The physician must explain the treatment to the patient, including that the treatment is experimental, and the patient, or the patient's legal representative, must acknowledge the explanation. A manufacturer, distributor, prescriber, dispenser, possessor, or user of such a treatment has no liability regarding the treatment. The outcome of manufacture, distribution, prescribing, dispensing, possession, or use of such a treatment may not be used by a federal agency to adversely impact review or approval of the treatment. The treatment must: (1) have successfully completed a phase 1 (initial, small scale) clinical trial; (2) remain under investigation in a clinical trial approved by the Food and Drug Administration (FDA); and (3) not be approved, licensed, or cleared for sale by the FDA.  


Ex Input:
SECTION 1. SHORT TITLE; TABLE OF CONTENTS.

    (a) Short Title.--This Act may be cited as the ``Federal Merit 
System Reauthorization Act of 2007''.
    (b) Table of Contents.--The table of contents is as follows:

Sec. 1. Short title; table of contents.
Sec. 2. Authorization of appropriations.
Sec. 3. Allegations of wrongdoing against Special Counsel or Deputy 
                            Special Counsel.
Sec. 4. Discrimination on the basis of sexual orientation prohibited.
Sec. 5. Procedures of the Merit Systems Protection Board.
Sec. 6. Procedures of the Office of Special Counsel.
Sec. 7. Reporting requirements.

SEC. 2. AUTHORIZATION OF APPROPRIATIONS.

    (a) Merit Systems Protection Board.--Section 8(a)(1) of the 
Whistleblower Protection Act of 1989 (5 U.S.C. 5509 note) is amended by 
striking ``2003, 2004, 2005, 2006, and 2007'' and inserting ``2008, 
2009, and 2010''.
    (b) Office of Special Counsel.--Section 8(a)(2) of the 
Whistleblower Protection Act of 1989 (5 U.S.C. 5509 note) is amended by 
striking ``2003, 2004, 2005, 2006, and 2007'' and inserting ``2008, 
2009, and 2010''.
    (c) Effective Date.--This section shall take effect as of October 
1, 2007.

SEC. 3. ALLEGATIONS OF WRONGDOING AGAINST SPECIAL COUNSEL OR DEPUTY 
              SPECIAL COUNSEL.

    (a) Definitions.--In this section--
            (1) the term ``Special Counsel'' refers to the Special 
        Counsel appointed under section 1211(b) of title 5, United 
        States Code;
            (2) the term ``Integrity Committee'' refers to the 
        Integrity Committee described in Executive Order 12993 
        (relating to administrative allegations against inspectors 
        general) or its successor in function (as identified by the 
        President); and
            (3) the terms ``wrongdoing'' and ``Inspector General'' have 
        the same respective meanings as under the Executive order cited 
        in paragraph (2).
    (b) Authority of Integrity Committee.--
            (1) In general.--An allegation of wrongdoing against the 
        Special Counsel (or the Deputy Special Counsel) may be 
        received, reviewed, and referred for investigation by the 
        Integrity Committee to the same extent and in the same manner 
        as in the case of an allegation against an Inspector General 
        (or a member of the staff of an Office of Inspector General), 
        subject to the requirement that the Special Counsel recuse 
        himself or herself from the consideration of any allegation 
        brought under this subsection.
            (2) Coordination with existing provisions of law.--This 
        section does not eliminate access to the Merit Systems 
        Protection Board for review under section 7701 of title 5, 
        United States Code. To the extent that an allegation brought 
        under this subsection involves section 2302(b)(8) of such 
        title, a failure to obtain corrective action within 120 days 
        after the date on which that allegation is received by the 
        Integrity Committee shall, for purposes of section 1221 of such 
        title, be considered to satisfy section 1214(a)(3)(B) of such 
        title.
    (c) Regulations.--The Integrity Committee may prescribe any rules 
or regulations necessary to carry out this section, subject to such 
consultation or other requirements as might otherwise apply.

SEC. 4. DISCRIMINATION ON THE BASIS OF SEXUAL ORIENTATION PROHIBITED.

    (a) Repudiation.--In order to dispel any public confusion, Congress 
repudiates any assertion that Federal employees are not protected from 
discrimination on the basis of sexual orientation.
    (b) Affirmation.--It is the sense of Congress that, in the absence 
of the amendment made by subsection (c), discrimination against Federal 
employees and applicants for Federal employment on the basis of sexual 
orientation is prohibited by section 2302(b)(10) of title 5, United 
States Code.
    (c) Discrimination Based on Sexual Orientation Prohibited.--Section 
2302(b)(1) of title 5, United States Code, is amended--
            (1) in subparagraph (D), by striking ``or'' at the end;
            (2) in subparagraph (E), by inserting ``or'' at the end; 
        and
            (3) by adding at the end the following:
                    ``(F) on the basis of sexual orientation;''.

SEC. 5. PROCEDURES OF THE MERIT SYSTEMS PROTECTION BOARD.

    (a) Proof of Exhaustion for Individual Right of Action.--Section 
1221(a) of title 5, United States Code, is amended--
            (1) by striking ``(a)'' and inserting ``(a)(1)''; and
            (2) by adding at the end the following:
    ``(2) For purposes of paragraph (1), an employee, former employee, 
or applicant for employment may demonstrate compliance with section 
1214(a)(3)(B) by--
            ``(A) submitting a copy of the complaint or other pleading 
        pursuant to which such employee, former employee, or applicant 
        sought corrective action from the Special Counsel with respect 
        to the personnel action involved; and
            ``(B) certifying that the Special Counsel did not provide 
        notice of intent to seek such corrective action to such 
        employee, former employee, or applicant within the 120-day 
        period described in such section 1214(a)(3)(B).''.
    (b) Individual Requests for Stays.--Section 1221(c) of title 5, 
United States Code, is amended by striking paragraph (2) and inserting 
the following:
    ``(2) Any stay requested under paragraph (1) shall be granted 
within 10 calendar days (excluding Saturdays, Sundays, and legal 
holidays) after the date the request is made, if the Board determines 
that the employee, former employee, or applicant has demonstrated that 
protected activity described under section 2302(b)(8) was a 
contributing factor to the personnel action involved. If the stay 
request is denied, the employee, former employee, or applicant may 
submit an interlocutory appeal for expedited review by the Board.''.
    (c) Joining Subsequent and Related Claims With Pending 
Litigation.--
            (1) In general.--Section 1221 of title 5, United States 
        Code, is amended--
                    (A) by redesignating subsections (h), (i), and (j) 
                as subsections (i), (j), and (k), respectively; and
                    (B) inserting after subsection (g) the following:
    ``(h) During a pending proceeding, subsequent personnel actions may 
be joined if the employee, former employee, or applicant for employment 
demonstrates that retaliation for protected activity at issue in the 
pending proceeding was a contributing factor to subsequent alleged 
prohibited personnel practices.''.
            (2) Conforming amendment.--Section 1222 of title 5, United 
        States Code, is amended by striking ``section 1221(i)'' and 
        inserting ``section 1221(j)''.
    (d) Procedural Due Process.--Section 1204(b)(1) of title 5, United 
States Code, is amended by inserting ``in accordance with regulations 
consistent with the Federal Rules of Civil Procedure, so far as 
practicable'' before the period.
    (e) Attorney Fees.--Section 7701(g)(1) of title 5, United States 
Code, is amended by striking ``if the employee or applicant is the 
prevailing party and'' and inserting ``if the claim or claims raised by 
the employee or applicant were not frivolous, unreasonable, or 
groundless; the case was a substantial or significant factor in the 
agency's action providing some relief or benefit to the employee or 
applicant; and''.

SEC. 6. PROCEDURES OF THE OFFICE OF SPECIAL COUNSEL.

    (a) Investigations of Alleged Prohibited Personnel Practices.--
Section 1212(e) of title 5, United States Code, is amended by striking 
``may prescribe such regulations as may be necessary to perform the 
functions'' and inserting ``shall prescribe such regulations as may be 
necessary to carry out subsection (a)(2) and may prescribe any 
regulations necessary to carry out any of the other functions''.
    (b) Mandatory Communications With Complainants.--
            (1) Contact information.--Section 1214(a)(1)(B) of title 5, 
        United States Code, is amended by striking clause (ii) and 
        inserting the following:
            ``(ii) shall include the name and contact information of a 
        person at the Office of Special Counsel who--
                    ``(I) shall be responsible for interviewing the 
                complainant and making recommendations to the Special 
                Counsel regarding the allegations of the complainant; 
                and
                    ``(II) shall be available to respond to reasonable 
                questions from the complainant regarding the 
                investigation or review conducted by the Special 
                Counsel, the relevant facts ascertained by the Special 
                Counsel, and the law applicable to the allegations of 
                the complainant.''.
            (2) Statement after termination of investigation.--Section 
        1214(a)(2)(A)(iv) of title 5, United States Code, is amended by 
        striking ``a response'' and inserting ``specific responses''.
    (c) Qualifications of Special Counsel.--The third sentence of 
section 1211(b) of title 5, United States Code, is amended by striking 
``position.'' and inserting ``position and has professional experience 
that demonstrates an understanding of and a commitment to protecting 
the merit based civil service.''.
    (d) Alternative Dispute Resolution Program of the Office of Special 
Counsel.--Section 1212 of title 5, United States Code, is amended by 
adding at the end the following:
    ``(h) The Office of Special Counsel shall by regulation provide for 
one or more alternative methods for settling matters subject to the 
jurisdiction of the Office which shall be applicable at the election of 
an employee, former employee, or applicant for employment or at the 
direction of the Special Counsel with the consent of the employee, 
former employee, or applicant concerned. In order to carry out this 
subsection, the Special Counsel shall provide for appropriate offices 
in the District of Columbia and other appropriate locations.''.
    (e) Substantial Likelihood Determinations.--Section 1213 of title 
5, United States Code, is amended--
            (1) in subsection (b), by striking ``15 days'' and 
        inserting ``45 days''; and
            (2) in subsection (c)(1), by inserting ``, after consulting 
        with the person who made the disclosure on how to characterize 
        the issues,'' after ``appropriate agency head''.
    (f) Determination of Statutory Requirements Met.--Section 1213(e) 
of title 5, United States Code, is amended--
            (1) in paragraph (3), by striking ``subsection (e)(1)'' and 
        inserting ``paragraph (1)'';
            (2) by redesignating paragraphs (3) and (4) as paragraphs 
        (4) and (5), respectively; and
            (3) by inserting after paragraph (2) the following:
    ``(3) Upon receipt of any report of the head of an agency required 
under subsection (c), if the Special Counsel is unable to make a 
determination under paragraph (2)(A) or (B), the Special Counsel shall 
require the agency head to submit any additional information necessary 
for the Special Counsel to make such determinations before any 
information is transmitted under paragraph (4).''.
    (g) Public and Internet Access for Agency Investigations.--Section 
1219 of title 5, United States Code, is amended by striking subsections 
(a) and (b) and inserting the following:
    ``(a) The Special Counsel shall maintain and make available to the 
public (including on the website of the Office of Special Counsel)--
            ``(1) a list of noncriminal matters referred to heads of 
        agencies under subsection (c) of section 1213, together with--
                    ``(A) reports from heads of agencies under 
                subsection (c)(1)(B) of such section relating to such 
                matters;
                    ``(B) comments submitted under subsection (e)(1) of 
                such section relating to such matters, if the person 
                making the disclosure consents; and
                    ``(C) comments or recommendations by the Special 
                Counsel under subsection (e)(4) of such section 
                relating to such matters;
            ``(2) a list of matters referred to heads of agencies under 
        section 1215(c)(2);
            ``(3) a list of matters referred to heads of agencies under 
        subsection (e) of section 1214, together with certifications 
        from heads of agencies under such subsection; and
            ``(4) reports from heads of agencies under section 
        1213(g)(1).
    ``(b) The Special Counsel shall take steps to ensure that any list 
or report made available to the public or placed on the website of the 
Office of Special Counsel under this section does not contain any 
information the disclosure of which is prohibited by law or by 
Executive order requiring that information be kept secret in the 
interest of national defense or the conduct of foreign affairs.''.

SEC. 7. REPORTING REQUIREMENTS.

    (a) Merit Systems Protection Board.--Each annual report submitted 
by the Merit Systems Protection Board under section 1206 of title 5, 
United States Code, shall, with respect to the period covered by such 
report, include--
            (1) the number of cases and alleged violations of section 
        2302 of such title 5 filed with the Board for each agency, 
        itemized for each prohibited personnel practice;
            (2) the number of cases and alleged violations of section 
        2302 of such title 5 that the Board determines for each agency, 
        itemized for each prohibited personnel practice and compared to 
        the total number of cases and allegations filed with the Board 
        for each, both with respect to the initial decisions by 
        administrative judges and final Board decisions;
            (3) the number of cases and allegations in which corrective 
        action was provided, compared to the total number of cases and 
        allegations filed with the Board for each, itemized separately 
        for settlements and final Board decisions; and
            (4) with respect to paragraphs (8) and (9) of section 2302 
        (b) of such title 5, the number of cases in which the Board has 
        ruled in favor of the employee on the merits of the claim 
        compared to the total number of cases and allegations filed 
        with the Board for each, where findings of fact and conclusions 
        of law were issued on whether those provisions were violated, 
        independent from cases disposed by procedural determinations, 
        including a separate itemization of both initial decisions by 
        administrative judges and final Board decisions for each 
        category.
    (b) Office of Special Counsel.--Each annual report submitted under 
section 1218 of title 5, United States Code, by the Special Counsel or 
an employee designated by the Special Counsel shall, with respect to 
the period covered by such report, include--
            (1) the number of cases and allegations for each prohibited 
        personnel practice, delineated by type of prohibited personnel 
        practice;
            (2) for each type of prohibited personnel practice, the 
        number of cases and allegations as to which the Office of 
        Special Counsel found reasonable grounds to believe section 
        2302 of such title 5 had been violated;
            (3) for each type of prohibited personnel practice, the 
        number of cases and allegations as to which the Office of 
        Special Counsel referred the complaint for full field 
        investigation;
            (4) for each prohibited personnel practice, the number of 
        cases and allegations as to which the Office of Special Counsel 
        recommended corrective action;
            (5) for each prohibited personnel practice, the number of 
        cases and allegations as to which the Office of Special Counsel 
        conducted a mediation or other form of alternative dispute 
        resolution, with statistics and illustrative examples 
        describing the results with particularity;
            (6) the number of instances in which the Office of Special 
        Counsel referred disclosures submitted under section 1213 of 
        such title 5 to an agency head, without any finding under 
        subsection (c) or (g) of such section;
            (7) a statistical tabulation of results for each customer 
        satisfaction survey question, both with respect to allegations 
        of prohibited personnel practice submitted under section 1214 
        of such title 5 and disclosures submitted under section 1213 of 
        such title; and
            (8) for each provision under section 1216(a) (1) through 
        (5) and (c) of such title 5, the number of cases and 
        allegations, the number of field investigations opened, the 
        number of instances in which corrective action was sought, and 
        the number of instances in which corrective action was 
        obtained.
    (c) Annual Survey.--Section 13(a) of the Act entitled ``An Act to 
reauthorize the Office of Special Counsel, and for other purposes'', 
approved October 29, 1994 (5 U.S.C. 1212 note; Public Law 103-424) is 
amended in the first sentence by inserting ``, including individuals 
who disclose information to the Office of Special Counsel under section 
1213'' before the period.

Ex Output:

Federal Merit System Reauthorization Act of 2007 - Amends the Whistleblower Protection Act of 1989 to authorize appropriations for FY2008-FY2010 for the Merit Systems Protection Board (MSPB) and the Office of Special Counsel (OSC).

Repudiates assertions that federal employees are not protected from discrimination on the basis of sexual orientation. Expresses the sense of Congress that discrimination on such basis against federal employees and applicants is currently prohibited. Prohibits any federal employee who has authority to take, direct, recommend, or approve any personnel action from discriminating for or against any federal employee or applicant on such basis.

Revises procedures of the MSPB and OSC, including by requiring the MSPB to use the National Labor Relations Board model for procedural due process and by requiring the OSC to prescribe regulations necessary to receive and investigate allegations of prohibited personnel practices.

Requires the Special Counsel to have professional experience that demonstrates an understanding of and a commitment to protecting the merit based civil service.

Requires the OSC to publish specified whistleblower disclosures and reports.

Sets forth MSPB and OSC reporting requirements with respect to incidences of prohibited personnel practices.